Aclaris Therapeutics, Inc. ( ACRS) - Key Metrics
ACRS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.15 | -$0.14 | -$0.14 |
| 2026Q1 | $0.02 | -$0.15 | -$0.14 | -$0.14 |
| 2025Q4 | $0.01 | -$0.16 | -$0.11 | -$0.11 |
| 2025Q3 | $0.03 | -$0.12 | -$0.09 | -$0.09 |
| 2025Q2 | $0.01 | -$0.13 | -$0.08 | -$0.08 |
ACRS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.82 |
| 2026Q1 | 0% | -6.25 |
| 2025Q4 | 0% | -4.70 |
| 2025Q3 | 0% | -3.96 |
| 2025Q2 | 0% | -2.73 |
ACRS
Price: $6.17
52 week price:
Earnings Per Share: -0.58 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 2.0 million
Ebitda: -18.6 millionMarket Capitalization: 861.7 million